Navigation Links
New Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors
Date:8/17/2009

MIAMI, Aug. 17 /PRNewswire/ -- Stereotactic body radiotherapy (SBRT) is a highly effective alternative treatment for some cancer patients with spinal metastases, reported in new research from The University of Texas in Houston, according to James G. Schwade, M.D. Executive Director of the CyberKnife Centers of Miami and Palm Beach.

(www.cyberknifemiami.com)

"This data confirms the established method of cancer treatment used on spinal tumors and other hard to reach areas of the body, due to the precisely targeted radiation dose and non-invasive nature of radiosurgery," said Dr. Schwade.

The study was presented at the American Association of Neurological Surgeons annual meeting in San Diego.

"SBRT offers patients a minimally invasive treatment option they previously did not have," said Dr. Eric L. Chang. "We are also able to offer patients a degree of pain control and to decrease their pain medications, minimizing the side effects from those medications."

In the study, researchers evaluated 121 cancer patients with metastases to the spine who underwent intensity-modulated, near simultaneous, CT image-guided SBRT, said Dr. Chang.

Researchers used a stereotactic body frame system consisting of a whole-body vacuum cushion and plastic fixation sheet used to immobilize patients for the treatment period, which lasts approximately one hour.

The team performed MR imaging of the spine within 30 days of patient enrollment, every three months for the first year and every six months after that. Patients also evaluated their own pain and other discomfort using instruments including the validated Brief Pain Inventory and the M.D. Anderson Symptom Inventory.

The CyberKnife Centers of Miami and Palm Beach serve the Palm Beach, Broward and Miami Dade County areas with outpatient facilities treating cancer patients with stereotactic radiosurgery utilizing the CyberKnife. For more information please visit http://www.morsecyberknife.com or http://www.ca123.com.


'/>"/>
SOURCE CyberKnife Centers of Miami and Palm Beach
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Community pharmacists can help improve ... the pharmacy through a custom-built medication synchronization program, Cardinal ... and owner at Schieber Family Pharmacy in ... a lot of patients enrolled in this medication synchronization ... a win for the patient, and it,s a win ...
(Date:2/11/2016)... DIEGO , Feb. 11, 2016 ... groundbreaking cell-isolation method that opens the door to ... until now have been impossible to isolate with ... to isolate specific tumor types in various stages ... genetic variants of these cells that are clinically ...
(Date:2/11/2016)... 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) announced ... February 25 at 11:30 a.m. Eastern Time to discuss its ... www.ionispharma.com . A webcast replay will be ... --> www.ionispharma.com . A webcast replay will be available ... Interested parties may listen to the call by dialing ...
Breaking Medicine Technology:
(Date:2/11/2016)... Alpharetta, Georgia (PRWEB) , ... February 11, 2016 ... ... Physicians Group (DMPG) will use the action analytics leader’s population health solutions, ... analytics and clinical support to the Atlanta-area healthcare system. Details of the contract ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... wide range of cosmetic procedures. Along with performing procedures, the magazine also highlights ... of many cosmetic procedures. One of the most common procedures he performs is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Image One USA veteran ... market, and it’s the buildings of Nashville that will benefit. , “I’ve enjoyed being ... relocate to Nashville, there was no question that I would bring my business with ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health ... up for their simultaneous grand openings in March. All seven practices are set ... probably wondering, is reversing diabetes possible? According to this 2011 CNN article it ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... Plastic and Reconstructive Surgery, Dallas plastic surgeon , Dr. Rod J. Rohrich, ... rhinoplasty surgery . Dr. Rohrich outlines recommendations for rhinoplasty surgeons when addressing this ...
Breaking Medicine News(10 mins):